View |
|
DRP-6527-06
|
Meropenem (as Trihydrate)
|
Meropin 1000
|
1 g
|
Powder for Solution for Injection (IV)
|
Antibacterial (Carbapenem)
|
Zeiss Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
07 April 2022
|
12 February 2026
|
View |
|
DRP-6739-02
|
Zinc (as sulfate monohydrate)
|
Tgzincmax
|
55 mg/5 mL
|
Syrup
|
Mineral
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
-
|
20 May 2022
|
17 April 2027
|
View |
|
DRP-7074-06
|
Meropenem (as trihydrate)
|
Morep 1000
|
1 g
|
Powder for Injection (IV)
|
Antibacterial
|
Daffodills Pharmaceuticals Ltd.
|
India
|
-
|
07 April 2022
|
06 March 2027
|
View |
|
DRP-7830-01
|
Digoxin
|
Digoxare
|
250 mcg/mL
|
Solution for Injection (I.V.)
|
Digitalis Glycoside
|
Anfarm Hellas S.A
|
Greece
|
Renewal
|
27 October 2022
|
20 April 2028
|
View |
|
DRP-7993-03
|
Rosuvastatin (as calcium)
|
Rovasu 20
|
20 mg
|
Film-Coated Tablet
|
HMG-CoA Reductase Inhibitor
|
Bafna Pharmaceuticals Limited
|
India
|
Renewal
|
25 October 2023
|
27 September 2028
|
View |
|
DRP-8204-09
|
Paracetamol + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
|
Neo-S
|
500 mg/ 25 mg/ 2 mg
|
Tablet
|
Analgesic/ Antipyretic/ Nasal Decongestant/ Antihistamine
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
12 May 2024
|
28 May 2029
|
View |
|
DRP-8453-01
|
Azithromycin (as Dihydrate)
|
Zenith
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolides)
|
Ind-Swift Limited
|
India
|
-
|
07 April 2022
|
19 December 2024
|
View |
|
DRP-8637-08
|
Butamirate Citrate
|
Sycof-S
|
50 mg
|
Sustained-Release Tablet
|
Antitussives
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
-
|
07 April 2022
|
20 January 2025
|
View |
|
DRP-8781-01
|
Paracetamol
|
None
|
500 mg
|
Tablet
|
Analgesic/Antipyretic
|
Hebei Tiancheng Pharmaceutical Co., Ltd
|
China
|
-
|
07 April 2022
|
19 March 2025
|
View |
|
DRP-9350-04
|
Salbutamol (as sulfate)
|
Spasmazol
|
100 mcg per actuation Suspension Metered Dose Inhaler
|
|
Selective Beta-2-adrenoreceptor Agonist
|
Beximco Pharmaceuticals Ltd
|
Bangladesh
|
-
|
07 April 2022
|
04 December 2025
|
View |
|
DRP-9969-01
|
Fluconazole
|
Fucozole
|
150 mg
|
Capsule
|
Antifungal
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
-
|
07 April 2022
|
03 February 2027
|
View |
|
DRP-10221-02
|
Ascorbic Acid + Cholecalciferol (Vitamin D3) + Zinc
|
HighCee Plus D
|
500 mg (equivalent to 562.50 mg Sodium Ascorbate)/ 400 IU/ 20 mg (equivalent to 54.90 mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamins/Mineral
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
07 April 2022
|
12 August 2026
|
View |
|
DRP-10477-01
|
Metformin hydrochloride
|
Glyformet
|
1 g
|
Extended Release Tablet
|
Oral hypoglycemic Agent (Biguanide)
|
Globela Pharma Private Limited
|
India
|
-
|
07 April 2022
|
30 September 2026
|
View |
|
DRP-10486-01
|
Ascorbic Acid + Zinc + Cholecalciferol (Vitamin D3)
|
Sovit-Pro
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)/25 mg (equivalent to 68.62 Zinc Sulfate Monohydrate)/1,000 IU Capsule
|
|
Vitamins/Mineral
|
San Marino Laboratories Corporation
|
Philippines
|
-
|
07 April 2022
|
04 October 2026
|
View |
|
DRP-10735-01
|
Olmesartan medoxomil
|
Olmesa
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Hetero Labs Limited (Unit V)
|
India
|
-
|
07 April 2022
|
15 November 2026
|
View |
|
DRP-10801-03
|
Sodium bicarbonate
|
Sobicard
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V. Infusion)
|
Electrolyte Replenisher/Systemic Alkalinising Agent
|
BCWorld Pharm. Co., Ltd
|
Korea
|
-
|
07 April 2022
|
21 December 2026
|
View |
|
DRP-10997-01
|
Hydroxychloroquine sulfate
|
Mediquine
|
200 mg
|
Tablet
|
Antimalarial (Aminoquinolone)
|
Laurus Labs Limited (Unit 2)
|
India
|
-
|
07 April 2022
|
29 December 2026
|
View |
|
DRP-11007-01
|
Citicoline
|
Armocoline
|
250 mg/mL
|
Solution for Injection (IM/IV)
|
Psychostimulant/Nootropic
|
Union Korea Pharm Co., Ltd.
|
Korea
|
-
|
07 April 2022
|
03 January 2027
|
View |
|
DRP-11059-01
|
Ketonalogues + Essential Amino Acids
|
Aloket
|
(see reverse formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Celogen Generics Private Ltd.
|
India
|
-
|
07 April 2022
|
21 January 2027
|
View |
|
DRP-11060-01
|
Salbutamol (as Sulfate)
|
Salusan
|
2.5 mg/2.5 mL
|
Solution for Nebulization
|
Selective beta-2 adrenergic agonist
|
Legency Remedies Pvt. Ltd.
|
India
|
-
|
07 April 2022
|
21 January 2027
|